{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:13:53Z","timestamp":1790140433079,"version":"4.0.1"},"update-to":[{"DOI":"10.1371\/journal.pbio.3000530","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000}}],"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"The Ministry of Education, Science, Sports and Culture of Japan","doi-asserted-by":"crossref","award":["17H04070"],"award-info":[{"award-number":["17H04070"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"The Ministry of Education, Science, Sports and Culture of Japan","doi-asserted-by":"crossref","award":["18K07056"],"award-info":[{"award-number":["18K07056"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"crossref","award":["23S001"],"award-info":[{"award-number":["23S001"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"DOI":"10.1371\/journal.pbio.3000530","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:42:30Z","timestamp":1573846950000},"page":"e3000530","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Type I interferon limits mast cell\u2013mediated anaphylaxis by controlling secretory granule homeostasis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-1544","authenticated-orcid":true,"given":"Toshihiko","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Shimabukuro-Demoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemitsu","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-0456","authenticated-orcid":true,"given":"Noriko","family":"Toyama-Sorimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"2","key":"pbio.3000530.ref001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"JM Gonzalez-Navajas","year":"2012","journal-title":"Nature reviews Immunology"},{"issue":"3","key":"pbio.3000530.ref002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2015.12.027","article-title":"Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes","volume":"164","author":"CT Ng","year":"2016","journal-title":"Cell"},{"issue":"1","key":"pbio.3000530.ref003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gene.2015.09.058","article-title":"The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases","volume":"576","author":"CM Lopez de Padilla","year":"2016","journal-title":"Gene"},{"issue":"7","key":"pbio.3000530.ref004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0969-2126(03)00120-5","article-title":"The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding","volume":"11","author":"JH Chill","year":"2003","journal-title":"Structure"},{"issue":"9","key":"pbio.3000530.ref005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ni.2667","article-title":"Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1","volume":"14","author":"NA de Weerd","year":"2013","journal-title":"Nature immunology"},{"issue":"5","key":"pbio.3000530.ref006","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"LC Platanias","year":"2005","journal-title":"Nature reviews Immunology"},{"issue":"4","key":"pbio.3000530.ref007","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"GR Stark","year":"2012","journal-title":"Immunity"},{"key":"pbio.3000530.ref008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses","volume":"8","author":"A Majoros","year":"2017","journal-title":"Front Immunol"},{"key":"pbio.3000530.ref009","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3389\/fimmu.2018.03047","article-title":"IRF and STAT Transcription Factors\u2014From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies","volume":"9","author":"TH Mogensen","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"1","key":"pbio.3000530.ref010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"LB Ivashkiv","year":"2014","journal-title":"Nature reviews Immunology"},{"issue":"20","key":"pbio.3000530.ref011","doi-asserted-by":"crossref","first-page":"14111","DOI":"10.1074\/jbc.M511797200","article-title":"Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation","volume":"281","author":"HH Ho","year":"2006","journal-title":"The Journal of biological chemistry"},{"key":"pbio.3000530.ref012","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3389\/fimmu.2018.01886","article-title":"STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response","volume":"9","author":"MH Tsai","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"14","key":"pbio.3000530.ref013","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1074\/jbc.271.14.8057","article-title":"Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor","volume":"271","author":"CH Yang","year":"1996","journal-title":"The Journal of biological chemistry"},{"issue":"11","key":"pbio.3000530.ref014","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"P Valent","year":"2017","journal-title":"Blood"},{"issue":"9","key":"pbio.3000530.ref015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM199202273260912","article-title":"Systemic mastocytosis","volume":"326","author":"KF Austen","year":"1992","journal-title":"N Engl J Med"},{"issue":"9","key":"pbio.3000530.ref016","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"HC Kluin-Nelemans","year":"1992","journal-title":"N Engl J Med"},{"issue":"11","key":"pbio.3000530.ref017","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ajh.24553","article-title":"Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management","volume":"91","author":"A. Pardanani","year":"2016","journal-title":"Am J Hematol"},{"issue":"4","key":"pbio.3000530.ref018","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients","volume":"119","author":"P Casassus","year":"2002","journal-title":"Br J Haematol"},{"issue":"12","key":"pbio.3000530.ref019","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.21561","article-title":"Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine","volume":"84","author":"KH Lim","year":"2009","journal-title":"Am J Hematol"},{"issue":"6","key":"pbio.3000530.ref020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2013.08.045","article-title":"Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation","volume":"132","author":"AM Siegel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"pbio.3000530.ref021","first-page":"606","article-title":"Interferon-alpha\/beta inhibits IgE-dependent histamine release from rat mast cells","volume":"66","author":"M Swieter","year":"1989","journal-title":"Immunology"},{"issue":"1","key":"pbio.3000530.ref022","first-page":"12","article-title":"Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells","volume":"86","author":"EY Bissonnette","year":"1995","journal-title":"Immunology"},{"issue":"7","key":"pbio.3000530.ref023","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"S Wernersson","year":"2014","journal-title":"Nature reviews Immunology"},{"key":"pbio.3000530.ref024","first-page":"569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"TC Moon","year":"2014","journal-title":"Frontiers in immunology"},{"issue":"5","key":"pbio.3000530.ref025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism","volume":"14","author":"C Settembre","year":"2013","journal-title":"Nature reviews Molecular cell biology"},{"issue":"6","key":"pbio.3000530.ref026","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"C Settembre","year":"2013","journal-title":"Nature cell biology"},{"issue":"5939","key":"pbio.3000530.ref027","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"M Sardiello","year":"2009","journal-title":"Science"},{"issue":"228","key":"pbio.3000530.ref028","doi-asserted-by":"crossref","first-page":"ra42","DOI":"10.1126\/scisignal.2002790","article-title":"The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis","volume":"5","author":"A Roczniak-Ferguson","year":"2012","journal-title":"Science signaling"},{"issue":"5","key":"pbio.3000530.ref029","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"C Settembre","year":"2012","journal-title":"The EMBO journal"},{"issue":"12","key":"pbio.3000530.ref030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/intimm\/dxx063","article-title":"Lysosome biogenesis regulated by the amino-acid transporter SLC15A4 is critical for functional integrity of mast cells","volume":"29","author":"T Kobayashi","year":"2017","journal-title":"Int Immunol"},{"issue":"2","key":"pbio.3000530.ref031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","article-title":"Constitutive type I interferon modulates homeostatic balance through tonic signaling","volume":"36","author":"DJ Gough","year":"2012","journal-title":"Immunity"},{"issue":"14","key":"pbio.3000530.ref032","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1089\/scd.2014.0553","article-title":"Distinguishing Mast Cell Progenitors from Mature Mast Cells in Mice","volume":"24","author":"JS Dahlin","year":"2015","journal-title":"Stem Cells Dev"},{"key":"pbio.3000530.ref033","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.1038\/srep13414","article-title":"STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3","volume":"5","author":"HS Kim","year":"2015","journal-title":"Sci Rep"},{"issue":"7542","key":"pbio.3000530.ref034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"BD McNeil","year":"2015","journal-title":"Nature"},{"key":"pbio.3000530.ref035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcp.2018.02.026","article-title":"STAT3 contributes to lysosomal-mediated cell death in a novel derivative of riccardin D-treated breast cancer cells in association with TFEB","volume":"150","author":"L Li","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"pbio.3000530.ref036","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1038\/s41467-018-07741-6","article-title":"Lysosomal protease deficiency or substrate overload induces an oxidative-stress mediated STAT3-dependent pathway of lysosomal homeostasis","volume":"9","author":"J Martinez-Fabregas","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"pbio.3000530.ref037","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2015.11.024","article-title":"Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis","volume":"138","author":"V Hox","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"pbio.3000530.ref038","first-page":"e23435","article-title":"STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties","volume":"2","author":"TH Mogensen","year":"2013","journal-title":"JAKSTAT"},{"issue":"16","key":"pbio.3000530.ref039","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"SM Holland","year":"2007","journal-title":"N Engl J Med"},{"issue":"7157","key":"pbio.3000530.ref040","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Y Minegishi","year":"2007","journal-title":"Nature"},{"key":"pbio.3000530.ref041","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2011.06387.x","article-title":"Hyper-IgE syndrome update","volume":"1250","author":"KJ Sowerwine","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"pbio.3000530.ref042","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4049\/jimmunol.158.1.393","article-title":"Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand","volume":"158","author":"T Ogasawara","year":"1997","journal-title":"Journal of immunology"}],"updated-by":[{"DOI":"10.1371\/journal.pbio.3000530","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000}}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3000530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T01:05:44Z","timestamp":1695431144000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3000530"}},"subtitle":[],"editor":[{"given":"Marc","family":"Schmidt-Supprian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3000530","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pbio.3000530","asserted-by":"object"}]},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}